Table 2.
Parameter | 5 mg Cd/L + 30 mg Zn/L | 5 mg Cd/L + 60 mg Zn/L | ||||||
---|---|---|---|---|---|---|---|---|
Main Effect of Cd |
Main Effect of Zn |
Interactive Effect of Cd + Zn |
Cd + Zn Effect vs. Cd Effect + Zn Effect Character of Cd-Zn Interaction |
Main Effect of Cd |
Main Effect of Zn |
Interactive Effect of Cd + Zn |
Cd + Zn Effect vs. Cd Effect + Zn Effect Character of Cd-Zn Interaction |
|
SOD | 17.47 ‡ | NS | NS | No interaction | NS | 19.68 ‡ | 10.17 † | +24 3 vs. −29 + 0 +24 vs. −29 4 |
GPx | 8.048 † | NS | NS | No interaction | NS | 8.596 † | 5.412 * | 0 vs. −30 + 0 0 vs. −30 Antagonism |
GR | 27.33 ‡ | 35.80 ‡ | 16.81 ‡ | 0 vs. +90 + 0 0 vs. +90 Antagonism |
4.274 * | 30.93 ‡ | 43.30 ‡ | −36 vs. +90 + 0 −36 vs. +90 4 |
CAT | 13.99 ‡ | 7.307 * | 5.000 * | 0 vs. −36 + 0 0 vs. −36 Antagonism |
19.49 ‡ | 9.254 † | NS | No interaction |
1 The outcomes of the ANOVA/MANOVA statistical test are expressed as F values and the level of statistical significance (p). F values having p < 0.05 are recognized statistically significant (where * p < 0.05, † p < 0.01, ‡ p < 0.001). NS—a lack of statistically significant effect (p > 0.05). 2 To describe the possible character of the interaction between Cd and Zn, the effect of co-administration of the two elements was compared to the sum of the effects of their action in the case of separate administration (Cd + Zn 30 effect vs. Cd effect + Zn 30 effect and Cd + Zn 60 effect vs. Cd effect + Zn 60 effect). The effects of Cd, Zn 30, Zn 60, Cd + Zn 30, and Cd + Zn 60 are shown as percentage differences (−, decrease; +, increase) vs. the control. The interaction between Cd and Zn (Cd-Zn 30 or Cd-Zn 60) was considered as antagonistic (antagonism) when the effect of co-administration of Cd and Zn (expressed as a percentage difference vs. the control) was below the sum of the effects noted in the case of their separate administration. 3 The values express percentage differences. 4 The description of the character of the interaction between Cd and Zn was impossible.